We are live on ! Find out more
FL

Fort LP Portfolio holdings

AUM $39.6M
1-Year Est. Return 37.11%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+37.11%
3 Year Est. Return
+56.81%
5 Year Est. Return
+128.28%
10 Year Est. Return
+343.79%
AUM
$239M
AUM Growth
+$53.9M
Cap. Flow
+$41.7M
Cap. Flow %
17.47%
Top 10 Hldgs %
6.49%
Holding
318
New
49
Increased
177
Reduced
69
Closed
23

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$738K
2
CI icon
Cigna
CI
+$716K
3
SLGN icon
Silgan Holdings
SLGN
+$709K
4
BIIB icon
Biogen
BIIB
+$671K
5
MOH icon
Molina Healthcare
MOH
+$671K

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$547K
2
EL icon
Estee Lauder
EL
+$442K
3
WM icon
Waste Management
WM
+$436K
4
JCI icon
Johnson Controls International
JCI
+$410K
5
PH icon
Parker-Hannifin
PH
+$397K

Sector Composition

Rank Sector Weight
1 Technology 25.16%
2 Healthcare 21.16%
3 Industrials 19.58%
4 Consumer Staples 13.33%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COO icon
276
Cooper Companies
COO
$13.7B
$248K 0.1%
2,948
-2,076
-41% -$159K
ROCK icon
277
Gibraltar Industries
ROCK
$1.36B
$244K 0.1%
+3,743
New +$221K
ARNA
278
DELISTED
Arena Pharmaceuticals Inc
ARNA
$242K 0.1%
+3,235
New +$216K
FICO icon
279
Fair Isaac
FICO
$29.7B
$240K 0.1%
565
-669
-54% -$284K
MSA icon
280
Mine Safety
MSA
$6.78B
$235K 0.1%
+1,751
New +$214K
BDX icon
281
Becton Dickinson
BDX
$43.8B
$230K 0.1%
+1,014
New +$249K
IONS icon
282
Ionis Pharmaceuticals
IONS
$9.25B
$229K 0.1%
+4,827
New +$268K
WING icon
283
Wingstop
WING
$3.74B
$226K 0.09%
1,654
-2,472
-60% -$363K
CSGS
284
DELISTED
CSG Systems International
CSGS
$216K 0.09%
5,273
-1,844
-26% -$76.8K
ROST icon
285
Ross Stores
ROST
$78.1B
$211K 0.09%
2,256
-1,274
-36% -$114K
MCD icon
286
McDonald's
MCD
$192B
$209K 0.09%
953
-1,295
-58% -$266K
SMPL icon
287
Simply Good Foods
SMPL
$943M
$208K 0.09%
9,422
-5,788
-38% -$135K
WLY icon
288
John Wiley & Sons Class A
WLY
$2.59B
$208K 0.09%
6,551
+457
+7% +$15.5K
NTAP icon
289
NetApp
NTAP
$33.3B
$205K 0.09%
+4,680
New +$204K
MZTI
290
The Marzetti Company
MZTI
$2.95B
$204K 0.09%
1,142
-1,983
-63% -$332K
BLD
291
DELISTED
TopBuild
BLD
$203K 0.09%
+1,189
New +$171K
CORT icon
292
Corcept Therapeutics
CORT
$9.78B
$188K 0.08%
+10,787
New +$172K
VGR
293
DELISTED
Vector Group Ltd.
VGR
$187K 0.08%
27,210
+2,240
+9% +$15.3K
TWNK
294
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$183K 0.08%
14,820
-13,731
-48% -$173K
SABR icon
295
Sabre
SABR
$704M
$122K 0.05%
18,689
-11,518
-38% -$85.3K
BALL icon
296
Ball Corp
BALL
$17.2B
– –
-3,547
Closed -$246K
BSX icon
297
Boston Scientific
BSX
$67.6B
– –
-8,564
Closed -$301K
CBRL icon
298
Cracker Barrel
CBRL
$1.17B
– –
-2,791
Closed -$310K
CCEP icon
299
Coca-Cola Europacific Partners
CCEP
$48.1B
– –
-7,691
Closed -$290K
DIS icon
300
Walt Disney
DIS
$168B
– –
-3,081
Closed -$344K
9 10 11
12
13

Similar funds

PL
Portman Ltd Grand Cayman, Cayman Islands $40M AUM 24.61% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
WFO
Wealthgate Family Office Boulder, Colorado $35.9M AUM 31.03% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Fort LP's Q3 2020 Portfolio in Review

As of Q3 2020, Fort LP held 318 positions worth $239M, up 29% from $185M the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Fort LP deployed $41.7M of net new capital in Q3 2020, opening 49 new positions and adding to 177 existing holdings. Its largest new stake was Neurocrine Biosciences: 6,378 shares worth $613K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Cable One, an estimated $377K trimmed.

  • Fort LP's largest Q3 2020 buy was Neurocrine Biosciences: 6,378 shares worth $613K.
  • Fort LP added most to Vertex Pharmaceuticals in Q3 2020, an estimated $553K increase.
  • Fort LP's biggest Q3 2020 reduction was Cable One, cutting an estimated $377K.
  • Fort LP fully exited Paramount Global Class B in Q3 2020, selling an estimated $547K.
  • Fort LP's ten largest holdings make up 6.5% of its $239M portfolio in Q3 2020.
  • Fort LP opened 49 new positions and closed 23 in Q3 2020.
  • Fort LP's portfolio value rose 29% quarter-over-quarter to $239M.

Based on Fort LP's 13F filing for Q3 2020, filed 13 Nov 2020.